Clinical Trial Update: Observational Study to Evaluate Bipolar Disorder Symptoms in Patients Presented With Schizophrenia or Depression

View source ↗

Summary

An observational study sponsored by AstraZeneca that completed and examined bipolar disorder symptoms in patients with schizophrenia, schizoaffective disorder, …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder Recurrent
• Schizoaffective Disorder
• Schizophrenia

Snippet

Sponsor: AstraZeneca | Conditions: Schizophrenia, Schizoaffective Disorder | Status: COMPLETED